化学
作用机理
抗真菌
对接(动物)
杀菌剂
抗真菌药
酶
生物化学
琥珀酸脱氢酶
细胞内
行动方式
结构-活动关系
生物活性
药物发现
甲壳素
抗氧化剂
药品
脱氢酶
噻二唑类
酶分析
细胞毒性
活动站点
三唑
组合化学
立体化学
新陈代谢
细胞膜
活性化合物
生物
药理学
作者
Wenjie Hu,Jingyi Yu,Xuebin Zhang,Jiaonan Li
标识
DOI:10.1186/s40538-026-01063-2
摘要
Abstract Background Plant pathogenic fungi pose a serious threat to global agricultural production. Traditional fungicides have become increasingly prominent due to multi-drug resistance. It is urgent to develop new and efficient fungicides with unique mechanisms of action that can effectively overcome drug resistance. Methods The structures of the synthesized compounds were characterized by 1 H NMR, 13 CNMR, and ESI–MS. Their antifungal activity was evaluated using the microbroth dilution method, and the target compounds with better antifungal effect were screened out. The mechanism of action was investigated by Scanning Electron Microscopy (SEM) combined with physiological and biochemical analyses. At the same time, further research is carried out through molecular docking simulation. Results Four aromatic butenamide derivatives were synthesized, and all structural characterizations were completed, with yields ranging from 19.5 to 56.6%. The antifungal activity results showed that compound 1 exhibited the strongest activity (MIC = 5 mg/mL), followed by compound 2 (MIC = 6.5 mg/mL), while compounds 3 and 4 showed weaker effects (MIC = 30 mg/mL and 31.25 mg/mL, respectively). The mechanism of compound 1 with activity was studied. It was found that compound 1 could destroy the integrity of fungal cell membrane and cause the leakage of intracellular substances. At the same time, it disrupts the dynamic balance of antioxidant enzymes and inhibits the normal physiological metabolism of fungi. The molecular docking results confirmed that the binding of the four derivatives to Succinate Dehydrogenase was generally more stable than that of Chitin Synthase. Conclusions This study can provide clear guidance for the design and optimization of aromatic butenamide derivatives.
科研通智能强力驱动
Strongly Powered by AbleSci AI